A private equity portfolio company needed a CTO who owned the number, not just the roadmap, to stabilise clinical data integrity before exit.
A growth-stage healthcare services platform was held by a private equity sponsor. The investment thesis relied on buy-and-build expansion. The strategy required integrating multiple acquired regional providers into a single operating model. Commercial momentum was strong at the top line. However, provider churn began to accelerate six months after the initial acquisition phase.
The issue was not clinical quality. The care delivery remained consistent. The friction was operational and digital. Providers could not access unified patient histories reliably. Billing codes from legacy systems conflicted with the central platform. This created administrative burden for clinic staff. It eroded trust in the platform’s reliability.
The sponsor’s value creation plan assumed that technology would enable scale. Instead, the fragmented data layer became a drag on retention. Monthly recurring revenue faced pressure. The underwriting case depended on net revenue retention targets. These targets were at risk. The existing technology leadership could not enforce standardisation across the newly acquired entities. Each acquisition brought a new silo of data. The central team lacked the authority to mandate change. The board needed the numbers to hold. They did not.
Lutfios entered the business to assess the technical debt and organisational structure. The first weeks revealed a disconnect between commercial promises and technical reality. The sales team sold a unified experience. The engineering team delivered a patchwork of integrations.
There was no single source of truth for patient data. Clinical records existed in three different formats across the portfolio. Reconciliation was manual. This introduced error rates that compounded over time. Providers spent hours correcting data rather than caring for patients.
The governance framework was absent. There were no enforced standards for data entry or system architecture. Each acquired entity retained its own legacy protocols. The central IT function acted as a support desk, not a strategic operator. It lacked line authority to dictate terms to subsidiary leaders.
The board packs reflected this ambiguity. Metrics on system uptime and data accuracy were self-reported and inconsistent. The sponsor could not verify the health of the asset. The technology stack was obstructing the commercial thesis. It was not merely a tool; it was the product experience. Without trust in the data, the platform had no defensibility. The problem was not a lack of software. It was a lack of accountable leadership.
Lutfios assumed the CTO seat with full line authority. This was not an advisory role. It was an executive mandate with accountability for the technology P&L and data governance. The objective was clear: re-architect the data layer to support the sponsor’s hold period goals.
The CTO reported directly to the CEO and engaged weekly with the operating partner. The authority extended to all acquired entities. Legacy contracts with vendors were reviewed and terminated where they hindered standardisation. New hiring freezes were imposed on non-core technical roles. Resources were redirected toward data integrity and integration.
The mandate included establishing a rigid governance framework. Data standards were defined and enforced across the entire portfolio. No acquired entity could onboard without meeting these baseline requirements. The CTO owned the roadmap for unifying the clinical data repository. This was not a suggestion. It was a condition of continued operation within the group.
The focus shifted from feature development to structural stability. The team stopped building new front-end interfaces. They focused on the backend plumbing. The goal was to make the invisible visible. The board required confidence in the metrics. The CTO was accountable for delivering that confidence.
The shift was qualitative but profound. Trust in the numbers returned to the board room. The weekly cadence of reporting moved from argument to analysis. The board pack no longer required footnotes explaining data discrepancies. The metrics were clean. They were comparable across the portfolio.
Provider churn stabilised. The administrative burden on clinics decreased as data flows automated. Providers could see patient histories accurately. This restored their confidence in the platform. The commercial team could once again sell on the promise of efficiency. The technology stack now supported the growth strategy. It did not obstruct it.
Margin pressure eased as manual reconciliation costs dropped. Working capital improved as billing errors declined. The cash conversion cycle tightened. The business operated on a single, coherent operating model. The fragmentation that had plagued the early integration phase was resolved.
The mandate had a defined end condition. Lutfios recruited a permanent CTO who aligned with the new governance standards. The transition plan was signed and executed over ninety days. The incoming leader inherited a stable architecture and a disciplined team. The sponsor retained an asset that matched its underwriting case. The platform was ready for the next phase of scale. The data layer was no longer a liability. It was a foundation.
This is the nature of embedded leadership. It closes the gap between decision and evidence. It ensures the operating model serves the owner’s intent.
If your portfolio company faces similar structural friction, speak with a Lutfios partner.